These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6121381)

  • 1. [Pharmacological effects on lower urinary tract dynamics].
    Hanus T
    Rozhl Chir; 1982 Jan; 61(1):42-6. PubMed ID: 6121381
    [No Abstract]   [Full Text] [Related]  

  • 2. [Palerol comp. Continued first drug of choice in pains caused by kidney and bile stones?].
    Oye I; Hertzenberg S
    Tidsskr Nor Laegeforen; 1980 Apr; 100(12):698-9. PubMed ID: 7414581
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conservative treatment of hypocontractile bladder emptying disturbances (author's transl)].
    Riccabona M
    Dtsch Med Wochenschr; 1981 Nov; 106(47):1579-82. PubMed ID: 6118249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunctional voiding in children secondary to internal sphincter dyssynergia: treatment with phenoxybenzamine.
    Smey P; King LR; Firlit CF
    Urol Clin North Am; 1980 Jun; 7(2):337-47. PubMed ID: 7404872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of medicamentous modification of the lower urinary tract].
    Schwenzer T
    Gynakologe; 1992 Aug; 25(4):247-57. PubMed ID: 1398254
    [No Abstract]   [Full Text] [Related]  

  • 6. Urodynamic and clinical effect of alpha-adrenergic blocker (phenoxybenzamine) in patients with benign prostatic hyperplasia.
    Chen KK; Chang LS; Chen MT; Huang JK; Yin JH; Lin SN; Lin AD
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Feb; 41(2):127-30. PubMed ID: 2458811
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticholinergics and urination disorders].
    Conquy S; Boccon-Gibod L; Boiteux JP
    J Urol (Paris); 1987; 93(8):505-9. PubMed ID: 3440843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental and clinical basis of pharmacotherapy in functional urodynamic disorders of the lower urinary tract in children].
    Seĭmivskiĭ DA; Tereshchenko AV
    Urol Nefrol (Mosk); 1985; (2):44-9. PubMed ID: 3158114
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological treatment of urinary incontinence and difficulty in emptying the bladder in women].
    Thind P; Lose G
    Ugeskr Laeger; 1985 Dec; 147(49):3989-92. PubMed ID: 2868553
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of anisotropine methylbromide on bladder function. (A clinical study).
    Bonney WW; Kaufman JJ
    West Med Med J West; 1967 Feb; 8(2):40-1. PubMed ID: 6072160
    [No Abstract]   [Full Text] [Related]  

  • 11. Diclofenac sodium and spasmolytic drugs in the treatment of ureteral colic: a comparative study.
    Başar I; Bircan K; Taşar C; Ergen A; Cakmak F; Remzi D
    Int Urol Nephrol; 1991; 23(3):227-30. PubMed ID: 1889968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of micturition disorders. Experiences with Spasmo-Urgenin].
    Rusch G
    Schweiz Rundsch Med Prax; 1970 Jan; 59(4):130-1. PubMed ID: 5519086
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of micturition disorders].
    Thüroff JW; Frohneberg D; Petri E; Jonas U
    Dtsch Med Wochenschr; 1981 Feb; 106(8):249-51. PubMed ID: 6110533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of children with an unstable bladder using the new anticholinergic drug Mictonorm (author's transl)].
    Heller K
    Padiatr Padol; 1982; 17(1):115-20. PubMed ID: 7058055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing study.
    Mazur D; Wehnert J; Dorschner W; Schubert G; Herfurth G; Alken RG
    Scand J Urol Nephrol; 1995 Sep; 29(3):289-94. PubMed ID: 8578271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation].
    Fernández Navarro MD; García Pérez M; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092
    [No Abstract]   [Full Text] [Related]  

  • 17. [Personal experiences with phenoxybenzamine (Dibenzyran) in the treatment of functional disorders of bladder emptying].
    Wehnert J; Sage S
    Z Urol Nephrol; 1988 Mar; 81(3):153-8. PubMed ID: 3388995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of oxybutynin on urinary symptoms in children with Williams-Beuren syndrome.
    Sammour ZM; Gomes CM; de Bessa J; Pinheiro MS; Kim CA; Honjo RS; Trigo-Rocha FE; Bruschini H; Srougi M
    J Urol; 2012 Jul; 188(1):253-7. PubMed ID: 22595063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of bladder-urethral dysfunction in childhood].
    De Grazia E; Cigna RM; Chiaramonte C; Lo Gaglio C
    Minerva Pediatr; 1988 Aug; 40(8):477-80. PubMed ID: 3221817
    [No Abstract]   [Full Text] [Related]  

  • 20. [Conservative therapy of prostate adenoma with phenoxybenzamine. Clinical aspects and urodynamics].
    Flamm J
    Fortschr Med; 1981 Nov; 99(43):1820-2. PubMed ID: 6171493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.